Credit Suisse Positive on NuVasive (NUVA), 'Momentum Improving, Driven by Critical Mass of New Products and Growth Drivers', Street High PT $75
Tweet Send to a Friend
Credit Suisse analyst Matt Miksic lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $83.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
